Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Full Dose Regimen (CLEAR-FDR Stroke Trial)

BACKGROUND AND PURPOSE: The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR) and CLEAR-Enhanced Regimen (CLEAR-ER) trials demonstrated safety of reduced dose recombinant tissue plasminogen activator (rt-PA) plus the glycoprotein 2b/3a inhibitor, eptifibati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stroke
Hlavní autoři: Adeoye, Opeolu, Sucharew, Heidi, Khoury, Jane, Vagal, Achala, Schmit, Pamela A., Ewing, Irene, Levine, Steven R., Demel, Stacie, Eckerle, Bryan, Katz, Brian, Kleindorfer, Dawn, Stettler, Brian, Woo, Daniel, Khatri, Pooja, Broderick, Joseph P., Pancioli, Arthur M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4550507/
https://ncbi.nlm.nih.gov/pubmed/26243231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.115.010260
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky